Luye Pharma Group's total assets for Q4 2025 were ¥32.84B, an increase of 2.52% from the previous quarter. LYPHF total liabilities were ¥14.19B for the fiscal quarter, a -8.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.